SuspendedPhase 3ketamine

Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient

Sponsored by University Hospital, Clermont-Ferrand

NCT ID
NCT00329394
Target Enrollment
56 participants
Start Date
2006-04
Est. Completion
2008-09

About This Study

The principal objective is to evaluate the analgesic effectiveness of the systemic ketamine on the control of the pain (average consumption of morphine at 48 hours) at the alcool-dependent patient, in carcinological surgery ORL. The effect coanalgesic is found for low dose of ketamine and action anti NMDA seems to have a stabilizing effect on this particular type of patient. This imbalance of the receivers, with a greater number of r-NMDA among these patients would involve it a better analgesic effectiveness and less effects dysphoric, to see an improvement on the syndrome of weaning. The secondary objectives evaluate the pain, the ground (dependence with alcohol), the first request analgesic, the tolerance and the signs psychic (syndrome of weaning...) and the satisfaction of the patient.

Conditions Studied

Alcoholic PatientCarcinological Surgery ORL

Interventions

  • ketamine

Eligibility

Age:18 Years - 70 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* patient alcohol-dependent having to undergo a carcinological surgery ORL with tracheotomy or tracheostomy, ASA 1-3

Exclusion Criteria:

* refusal of the patient
* counter-indications with the treatments,
* urgency
* the specific clinical context (final neoplasy, reanimation)
* the treatments for chronic pain containing morphinic

Study Locations (1)

Clermont-Ferrand University Hospital
Clermont-Ferrand, France

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source